Current role
Former CFO
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Former CFO
The proxy statement of Beam Therapeutics Inc. reports total compensation of $2,557,844 for Former CFO in fiscal 2023, including a base salary of $505,000. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Beam Therapeutics Inc. (BEAM)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Beam Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- John Evans CEO, Chief Accounting Officer, Board Member
- Sravan Emany CFO
- Sravan K. Emany CFO
- Chirfi Guindo Board Member
- Christi Shaw Board Member
- Graham Cooper Board Member
- John Maraganore Board Member
- John Maraganore, Ph.D. Board Member
- Kathleen Walsh Board Member
- Mark Fishman Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Beam Therapeutics Inc. (BEAM) | — | $505,000 | $2,557,844 |
| 2022 | Beam Therapeutics Inc. (BEAM) | — | $480,000 | $2,947,530 |
Recent activity
No call appearances or filed executive changes recorded yet.